By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche Molecular Systems today said that it has formed a research collaboration with Merck subsidiary Merck Sharp & Dohme, under which the drug firm will have access to Roche's microarray-based AmpliChip p53 Test for research purposes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.